Northann Corp（NCL）資訊與事件

$0.159

-0.007 (-4.16%)收盤時

NCL 資訊

8.506-15Newsfilter

Northann Corp. Regains Compliance with NYSE Listing Standards

4.503-02moomoo

NORTHANN CORP. CONFIRMS NYSE AMERICAN'S APPROVAL OF ITS STRATEGIC LISTING OPTIMIZATION PLAN

4.501-02Globenewswire

Northann Corp. Expands into Major North American Retail Market in 2026

8.512-31Benzinga

FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%

4.012-31Benzinga

U.S. Initial Jobless Claims Drop to 199,000, Beating Estimates

5.012-31Benzinga

Vanda Pharmaceuticals' NEREUS Receives FDA Approval, Shares Surge 17.5%

9.012-29Benzinga

Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab

2.012-26Benzinga

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%

9.512-26Benzinga

Davis Commodities Reports $95M Revenue in H1, Up 42.1%

9.512-24Benzinga

Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025

查看更多資訊

NCL 事件

12/23 11:50

Northann Corp Trading Resumes

Northann Corp trading resumes

12/23 10:50

Northann Corp Trading Halted, News Pending

Northann Corp trading halted, news pending

12/11 16:30

Northann Receives NYSE Warning for Non-Compliance with Listing Standards

Northann announced it received a notice from the staff of NYSE American that the company was not in compliance with the Exchange's continued listing standards under Section 1003 of the NYSE American Company Guide. Section 1003 requires a listed company to have stockholders' equity of $2M or more if the listed company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years.

查看更多事件

本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。